Incidence and severity prediction score of COVID-19 in people living with HIV (SCOVHIV): experience from the first and second waves of the pandemic in Indonesia

Background People living with HIV (PLHIV) have higher risk of COVID-19 infection and mortality due to COVID-19.

Health professionals should be able to assess PLHIV who are more likely to develop severe COVID-19 and provide appropriate medical treatment.

This study aimed to assess clinical factors associated with COVID-19 severity and developed a scoring system to predict severe COVID-19 infection among PLHIV.

Methods This retrospective cohort study evaluated PLHIV at four hospitals diagnosed with COVID-19 during the first and second wave COVID-19 pandemic in Indonesia.

The independent risk factors related to the severity of COVID-19 were identified with multivariate logistic regression.

Results 342 PLHIV were diagnosed with COVID-19, including 23 with severe-critical diseases.

The cumulative incidence up to December 2021 was 0.083 (95% CI 0.074–0.092).

Twenty-three patients developed severe-critical COVID-19, and the mortality rate was 3.2% (95% CI 1.61%–5.76%).

Having any comorbidity, CD4 count of < 200 cells/mm^3, not being on ART, and active opportunistic infection were independent risk factors for developing severe COVID-19.

SCOVHIV score was formulated to predict severity, with 1 point for each item.

A minimum score of 3 indicated a 58.4% probability of progressing to severe COVID-19.

This scoring system had a good discrimination ability with the area under the curve (AUC) of 0.856 (95% CI 0.775–0.936).

Conclusion SCOVHIV score, a four-point scoring system, had good accuracy in predicting COVID-19 severity in PLHIV.